Generic Pharmaceuticals - Publications - Faculty & Research

Web

Strategy Awards & Honors - Faculty & Research

Continue: Coke and Pepsi in 2010” with Renee Kim (HBS Case 711-462) and also winner in the Strategy and General Management category for “Apple Inc. in 2012” with Penelope Rossano (HBS Case 712-490). 2014 Frank Nagle : "Drivers and... View Details

15 Dec 2003
Research & Ideas

The New Global Business Manager

the general manager—the division head, or the CEO. We used to always talk about the CEO as being the grand strategic architect, sitting on top of the company and defining the priorities and making the strategic investments. Historically,... View Details

Keywords: by Cynthia Churchwell

09 Jan 2007
First Look

First Look: January 9, 2007

http://www.hbsp.harvard.edu/b01/en/common/item_detail.jhtml?id=707413 Teva Pharmaceutical Industries, Ltd. Harvard Business School Case 707-441 Purchase this case: http://www.hbsp.harvard.edu/b01/en/common/item_detail.jhtml?id=707441 ... View Details

Keywords: Martha Lagace

15 Jun 2007
Research & Ideas

Remembering Alfred Chandler

Chemical and Pharmaceutical Industries. In his lifetime, he produced a range of books, edited collections, and articles covering railways, management, global competition, anthracite coal, the career of Alfred P. Sloan, the nature of... View Details

Keywords: by Sean Silverthorne

Web

Harvard Business School

and Connecticut General Insurance Corporation, where Jones became the first African American board member. Otis Gates III MBA 1963 Otis Gates grew up in Roxbury and graduated from both Harvard College and HBS. In 1968, Gates began his... View Details

24 Jul 2018
First Look

New Research and Ideas, July 24, 2018

case:https://hbsp.harvard.edu/product/118054-PDF-ENG Harvard Business School Case 318-108 Hikma Pharmaceuticals Governance Journey The case opens with Said Darwazah, chairman and CEO of Hikma Pharmaceuticals, the multinational View Details

Keywords: Dina Gerdeman

13 Oct 2009
Research & Ideas

7 Lessons for Navigating the Storm

CEO Dan Vasella made counterintuitive moves by expanding Novartis's generic drug, vaccines, and consumer health businesses in spending heavily on acquisitions to offer alternatives to patented drugs. Meanwhile, he focused Novartis's View Details

Keywords: by Martha Lagace

January 2017 (Revised March 2017)
Case

Royal DSM: From Continuous Transformation to Organic Growth

By: William W. George, Carin-Isabel Knoop and Amram Migdal

Royal DSM CEO Feike Sijbesma was pondering the challenges of shifting DSM’s global organization from the constant transformations of the past 100 years to creating organic growth. When Sijbesma took the helm as CEO in 2007, he further pushed and completed the company’s... View Details

Keywords: Organic Growth; Organizational Change; M＆A; Mergers And Acquisitions; Divestment; Business Ventures; Business Divisions; Business Growth and Maturation; Restructuring; Change; Change Management; Transformation; Transition; Engineering; Chemicals; Mining; Ethics; Values and Beliefs; Finance; Capital Markets; Financial Markets; Food; Globalization; Global Strategy; Globalized Firms and Management; Globalized Markets and Industries; Health; Nutrition; History; Leadership; Leadership Development; Leadership Style; Leading Change; Management; Business or Company Management; Growth and Development Strategy; Growth Management; Management Practices and Processes; Management Style; Organizations; Corporate Social Responsibility and Impact; Mission and Purpose; Organizational Change and Adaptation; Organizational Culture; Organizational Design; Ownership; Public Ownership; Performance; Strategy; Adaptation; Consolidation; Corporate Strategy; Value; Value Creation; Pharmaceutical Industry; Pharmaceutical Industry; Pharmaceutical Industry; Pharmaceutical Industry; Pharmaceutical Industry; Europe; Netherlands

Citation

Educators

Purchase

Web

2024 Reunion Presentations - Alumni

large tech companies and retailers are making bold moves into the industry. These health care “entrants” aim to leverage their general skills in serving consumers to address barriers in health care delivery. Will these new entrants be... View Details

Research Summary

Overview

By: Andy Wu

How can technology entrepreneurs build competitive advantage from the ground up? Professor Andy Wu conducts scholarly research and develops course materials that document how technology entrepreneurs can (1) organize for innovation to create new market opportunities... View Details

Keywords: Strategy; Entrepreneurship; Venture Capital; Growth Management; Organizational Design; Organizational Structure; Technology Platform; Technological Innovation; Pharmaceutical Industry; Pharmaceutical Industry; Pharmaceutical Industry; Pharmaceutical Industry; Pharmaceutical Industry; United States; China; Southeast Asia; South Asia

10 Sep 2008
Research & Ideas

Long-Tail Economics? Give Me Blockbusters!

you can make money in many creative industries by selling specialized products to niche markets identified via the Internet. For example, the new CEO of GlaxoSmithKline, the pharmaceuticals giant, likens the search for blockbusters to... View Details

Keywords: by John Quelch; Pharmaceutical; Pharmaceutical

12 Dec 2022
Research & Ideas

Buy-In from Black Patients Suffers When Drug Trials Don’t Include Them

Moderna, a pharmaceutical company, announced in September 2020 that it would slow enrollment of its COVID-19 vaccine trials to better improve representation. The majority of study participants were white, although COVID-19 was... View Details

Keywords: by Scott Van Voorhis; Pharmaceutical; Pharmaceutical

Melvin R. Goodes

Goodes grew Warner-Lambert’s market value from $9 billion in 1991 to almost $60 billion in 1999. He helped the pharmaceutical company become a major player in the prescription drug industry and is responsible for striking a deal with... View Details

Keywords: Personal Care & Home Products

27 Jun 2005
Research & Ideas

The Potential Downside of Win-Win

the negotiation. In April 2001, the FTC filed a complaint accusing pharmaceutical companies Schering-Plough and Upsher-Smith of restricting trade. Upsher-Smith had been preparing to introduce a generic View Details

Keywords: by Max H. Bazerman

Profile

Rocio Parra

Why was getting a business education important to you? As a consultant, I had the opportunity to work in a variety of industries from pharmaceuticals and medical devices to government and consumer packaged goods. Through these... View Details

Keywords: Retail

Robert P. Luciano

Luciano generated top-level financial performance while streamlining Schering’s business operations. He divested Schering’s non-healthcare related business lines and was one of the first pharmaceutical... View Details

Keywords: Healthcare

01 Dec 2004
News

Finding a Balance

Do the rules of business change when a company’s product holds the power of life or death over its customers? That’s a question students must consider when discussing “Cipla,” a case about a $325 million Indian pharmaceutical company that... View Details

Keywords: Julia Hanna; Colleges, Universities, and Professional Schools; Educational Services

24 Apr 2014
News

Giving hope and inspiration to cancer patients around the globe

Every new day is a good day for Kathryn E. Giusti (MBA 1985) since that morning in 1996 when her oncologist told her to get her affairs in order because she had a rare blood cancer, with three years to live. Leveraging her past experience as a View Details

01 Mar 2007
News

In Brief

Q&A with Daniel Vasella. Initially regarded by critics as too inexperienced to lead a major pharmaceutical company, Daniel Vasella (PMD 57, 1989) has set a new standard for innovation as CEO of Novartis. The Winning Season. Last year, St.... View Details

Keywords: Corporate, Subsidiary, and Regional Managing Offices; Management

E. Gifford Upjohn

Upjohn played an instrumental role in supporting legislation requiring pharmaceutical companies to prove a drug’s effectiveness in clinical trials prior to its general release. A physician by training,... View Details